Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 11, 2001
Issued Date -
N/A
app pub date -
Mar 12, 1999
filing date -
Mar 18, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed is a method of reducing an immune response to a transplant in a recipient by treating said recipient with an amount of mesenchymal stem cells effective to reduce or inhibit host rejection of the transplant. The mesenchymal stem cells can be administered before, at the same time as, or after the transplant. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease, by treatment with mesenchymal stem cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully